Nasdaq Inc/ US6311031081 /
2024-05-17 10:00:00 PM | Chg. +0.5300 | Volume | Bid12:17:06 AM | Ask12:17:06 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
62.7600USD | +0.85% | 2.36 mill. Turnover: 103.89 mill. |
62.7700Bid Size: 300 | 62.8500Ask Size: 300 | 30.83 bill.USD | 1.37% | 29.89 |
GlobeNewswire
12:43 AM
LGI Homes Commemorates Annual Service Impact Day and Celebrates Employee Volunteerism
GlobeNewswire
12:11 AM
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Altimmune, Inc. Investors to Secure Counsel Before Importa...
GlobeNewswire
12:00 AM
ADSK Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Act...
GlobeNewswire
05-17
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
05-17
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
GlobeNewswire
05-17
AKRO Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Akero Therapeutics, Inc. Investors wit...
GlobeNewswire
05-17
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
GlobeNewswire
05-17
Nuvini (Nasdaq: NVNI) Announces Nasdaq Notification of Non-Compliance Regarding Delayed Form 20-F Fi...
GlobeNewswire
05-17
Primech Holdings Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price...
GlobeNewswire
05-17
Virios Therapeutics Announces Proposed Public Offering of Common Stock to Commence Preparations for ...
GlobeNewswire
05-17
QCR Holdings, Inc. Announces Annual Meeting Results and a Cash Dividend of $0.06 Per Share